Stay updated on Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 in the page footer.
    Difference
    0.0%
    Check dated 2025-11-30T08:40:14.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Additions clarify that Publications are provided voluntarily and are auto-filled from PubMed. Deletions remove older phrasing about these sources. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-23T00:47:11.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The Locations list adds Tainan, Taiwan, 704 and removes Tainan City, Taiwan, 704; a government funding notice block is deleted.
    Difference
    0.1%
    Check dated 2025-11-15T15:39:04.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    - Added a new publication citation for KEYNOTE-585 final analysis (Shitara et al., J Clin Oncol 2025) to the Publications section. - Removed the online-ahead-of-print citation for the same study. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-01T08:12:33.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision tag, replacing the previous v3.1.0. This updates core content with current operating status guidance and versioning.
    Difference
    1%
    Check dated 2025-10-03T10:54:04.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.1.0 and removes Drug Safety-related sections (Drugs, Counterfeit Drugs, Substandard Drugs) that were present in v3.0.2.
    Difference
    0.3%
    Check dated 2025-09-26T06:47:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page.